Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Tonix Pharmaceuticals Holding Corp. (TNXP) had Return on Equity of -13.85% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$3.29M |
|
$-32.01M |
|
$1.37M |
|
$1.92M |
|
$36.36M |
|
$-33.07M |
|
$1.06M |
|
$-32.01M |
|
$-32.01M |
|
$-32.01M |
|
$-32.01M |
|
$-32.01M |
|
$-32.01M |
|
$-33.07M |
|
$-32.61M |
|
8.92M |
|
8.92M |
|
$-3.59 |
|
$-3.59 |
|
| Balance Sheet Financials | |
$208.07M |
|
$42.57M |
|
$44.37M |
|
$252.44M |
|
$21.03M |
|
-- |
|
$0.27M |
|
$21.30M |
|
$231.14M |
|
$231.02M |
|
$231.14M |
|
10.17M |
|
| Cash Flow Statement Financials | |
$-60.19M |
|
$-3.51M |
|
$155.39M |
|
$99.68M |
|
$191.35M |
|
$91.67M |
|
$4.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.89 |
|
-- |
|
-- |
|
-- |
|
-- |
|
58.45% |
|
-1005.08% |
|
-1005.08% |
|
-- |
|
-972.95% |
|
-972.95% |
|
$-61.69M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.24 |
|
0.95 |
|
95.22 |
|
|
Return on Equity |
-13.85% |
-13.86% |
|
-12.68% |
|
-13.85% |
|
$22.73 |
|
$-6.91 |
|
$-6.75 |
|